PTGS2 and breast cancer: Consistently, COX-2 is abundantly expressed in breast cancer tissue [18] and its enforced over-expression in mammary gland epithelia of transgenic mice results in breast tumour development [19], suggesting that COX-2 might be an interesting therapeutic target in breast cancer.